BioCentury | Jul 1, 2020
Emerging Company Profile

With potential for re-dosing, Carmine’s gene therapy tech attracts Takeda as partner

...total funding to $9.4 million. The biotech has also received funding from Takeda Ventures and Esco Ventures...
BioCentury | Aug 14, 2019
Company News

Aug. 14 Company Quick Takes: Myriad plunges on sales concerns; plus AbbVie-Allergan, TB Alliance, Akari, Carmine

...be funded by Innovate UK’s Knowledge Transfer Partnership. Esco launches Carmine for vesicle-based drug delivery Esco Ventures...
Items per page:
1 - 2 of 2
BioCentury | Jul 1, 2020
Emerging Company Profile

With potential for re-dosing, Carmine’s gene therapy tech attracts Takeda as partner

...total funding to $9.4 million. The biotech has also received funding from Takeda Ventures and Esco Ventures...
BioCentury | Aug 14, 2019
Company News

Aug. 14 Company Quick Takes: Myriad plunges on sales concerns; plus AbbVie-Allergan, TB Alliance, Akari, Carmine

...be funded by Innovate UK’s Knowledge Transfer Partnership. Esco launches Carmine for vesicle-based drug delivery Esco Ventures...
Items per page:
1 - 2 of 2